Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-11-002180
Filing Date
2011-07-15
Accepted
2011-07-14 18:38:39
Documents
11
Period of Report
2011-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT oxbt_10k.htm 10-K 1732585
2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT oxbt_ex1023.htm EX-10.23 145312
3 EMPLOYMENT AGREEMENT oxbt_ex1027.htm EX-10.27 134337
4 RESIGNATION OF EMPLOYMENT AND CONSULTING AGREEMENT oxbt_ex1033.htm EX-10.33 66814
5 AMENDED AND RESTATED EMPLOYMENT AGREEMENT oxbt_ex1035.htm EX-10.35 134738
6 FORM OF INDEMNIFICATION AGREEMENT oxbt_ex1036.htm EX-10.36 36324
7 CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM oxbt_ex231.htm EX-23.1 3854
8 CERTIFICATION oxbt_ex311.htm EX-31.1 11701
9 CERTIFICATION oxbt_ex312.htm EX-31.2 11443
10 CERTIFICATION oxbt_ex321.htm EX-32.1 7155
11 CERTIFICATION oxbt_ex322.htm EX-32.2 7178
  Complete submission text file 0001354488-11-002180.txt   2292793
Mailing Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1109
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 11968799
SIC: 8731 Services-Commercial Physical & Biological Research